Harris John A, Sammarco Anne G, Swenson Carolyn W, Uppal Shitanshu, Kamdar Neil, Campbell Darrel, Evilsizer Sarah, DeLancey John O, Morgan Daniel M
Department of Obstetrics and Gynecology, University of Michigan, Ann Arbor, MI.
Department of Obstetrics and Gynecology, University of Michigan, Ann Arbor, MI.
Am J Obstet Gynecol. 2017 May;216(5):502.e1-502.e11. doi: 10.1016/j.ajog.2016.12.173. Epub 2017 Jan 9.
Healthcare teams that frequently follow a bundle of evidence-based processes provide care with lower rates of morbidity. Few process bundles to improve surgical outcomes in hysterectomy have been identified.
The purpose of this study was to investigate whether a bundle of 4 perioperative care processes is associated with fewer postoperative complications and readmissions for hysterectomies in the Michigan Surgical Quality Collaborative.
A bundle of perioperative care process goals was developed retrospectively with 30-day peri- and postoperative outcome data from the Hysterectomy Initiative in Michigan Surgical Quality Collaborative. All benign hysterectomies that had been performed between January 2013 and January 2015 were included. Based on evidence of lower complication rates after benign hysterectomy, the following processes were considered to be the "bundle": use of guideline-appropriate preoperative antibiotics, a minimally invasive surgical approach, operative duration <120 minutes, and avoidance of intraoperative hemostatic agent use. Each process was considered present or absent, and the number of processes was summed for a bundle score that ranged from 0-4. Cases with a score of zero were excluded. Outcomes measured were rates of complications (any and major) and hospital readmissions, all within 30 days of surgery. Postoperative events that were considered a "major complication" included acute renal failure, cardiac arrest that required cardiopulmonary resuscitation, central line infection, cerebral vascular accident, death, deep vein thrombosis, intestinal obstruction, myocardial infarction, pelvic abscess, pulmonary embolism, rectovaginal fistula, sepsis, surgical site infection (deep and organ-space), unplanned intubation, ureteral obstruction, and ureterovaginal and vesicovaginal fistula. The outcome "any complication" included all those events already described in addition to blood transfusion within 72 hours of surgery, urinary tract infection, and superficial surgical site infection. Outcomes were adjusted for patient demographics, surgical factors, and hospital-level clustering effects.
There were 16,286 benign hysterectomies available for analysis. Among all hysterectomies that were reviewed, 33.6% met criteria for all bundle processes; however, there was wide variation in the rate among the 56 hospitals in the study sample with 9.1% of cases at the lowest quartile and 60.4% at the highest quartile of hospitals that met criteria for all bundle processes. Overall, the rate of any complication was 6.8% and of any major complication was 2.3%. The rate of hospital readmissions was 3.6%. After adjustment for confounders, in cases in which all bundle criterion were met compared with cases in which all bundle criterion were not met, the rate of any complications increased from 4.3-7.8% (P<.001); major complications increased from 1.7-2.6% (P<.001), and readmissions increased from 2.6-4.1% (P<.001). After adjustment for confounders, hospitals with greater rates of meeting all 4 criteria were associated significantly with lower hospital-level rates of postoperative complications (P<.001) and readmissions (P<.001).
This multiinstitutional evaluation reveals that reduced morbidity and readmission are associated with rates of bundle compliance. The proposed bundle is a surgical goal, which is not possible in every case, and there is significant variation in the proportion of cases meeting all 4 bundle processes in Michigan hospitals. Implementation of evidence-based process bundles at a healthcare system level are worthy of prospective study to determine whether improvements in patient outcomes are possible.
经常遵循一系列循证流程的医疗团队提供的护理可降低发病率。目前已确定的用于改善子宫切除手术结局的流程束较少。
本研究的目的是调查密歇根手术质量协作组织中,一套包含4个围手术期护理流程的组合是否与子宫切除术后较少的并发症和再入院率相关。
根据密歇根手术质量协作组织子宫切除倡议中30天围手术期和术后结局数据,回顾性制定了一套围手术期护理流程目标。纳入2013年1月至2015年1月期间进行的所有良性子宫切除术。基于良性子宫切除术后较低并发症发生率的证据,以下流程被视为“流程束”:使用符合指南的术前抗生素、微创外科手术方法、手术持续时间<120分钟以及避免术中使用止血剂。每个流程被视为存在或不存在,并将流程数量相加得出范围为0至4的流程束分数。得分为零的病例被排除。测量的结局为并发症(任何并发症和主要并发症)发生率以及再入院率,均在术后30天内。被视为“主要并发症”的术后事件包括急性肾衰竭、需要心肺复苏的心脏骤停、中心静脉感染、脑血管意外、死亡、深静脉血栓形成(DVT)、肠梗阻、心肌梗死、盆腔脓肿、肺栓塞、直肠阴道瘘、脓毒症、手术部位感染(深部和器官间隙)、计划外插管、输尿管梗阻以及输尿管阴道瘘和膀胱阴道瘘。“任何并发症”结局包括上述所有事件以及手术72小时内输血、尿路感染和浅表手术部位感染。结局针对患者人口统计学特征、手术因素和医院层面的聚类效应进行了调整。
共有16286例良性子宫切除术可供分析。在所有接受评估的子宫切除术中,33.6%符合所有流程束标准;然而,研究样本中的56家医院之间该比例差异很大,在符合所有流程束标准的医院中,最低四分位数的病例占9.1%,最高四分位数的病例占60.4%。总体而言,任何并发症发生率为6.8%,任何主要并发症发生率为2.3%。再入院率为3.6%。在对混杂因素进行调整后,与未符合所有流程束标准的病例相比,符合所有流程束标准的病例中,任何并发症发生率从4.3%增至7.8%(P<.001);主要并发症发生率从1.7%增至2.6%(P<.001),再入院率从2.6%增至4.1%(P<.001)。在对混杂因素进行调整后,符合所有4项标准比例较高的医院与较低的医院层面术后并发症发生率(P<.001)和再入院率(P<.001)显著相关。
这项多机构评估表明,发病率和再入院率的降低与流程束依从率相关。所提出的流程束是一个手术目标,并非在每种情况下都可行,并且密歇根州各医院中符合所有4个流程束流程的病例比例存在显著差异。在医疗系统层面实施循证流程束值得进行前瞻性研究,以确定是否有可能改善患者结局。